Uniqgene
PrivateLast Round
Accelerator
Sep 26, 2025
Total Funding Raised
$185,000
Company Overview
Uniqgene is a biotechnology company that provides personalized wellness and performance solutions through genetic testing and AI-driven insights.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sports & Fitness, Precision Medicine, Sports Analytics, D2C Brands
Business Model
B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uniqgene Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Uniqgene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 26, 2025 | ||||
| Seed | Dec 15, 2022 | ||||
| Grant | Dec 8, 2022 |
Uniqgene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innogate | Grant |
| P4 Precision Medicine Accelerator | Accelerator |
Uniqgene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Uniqgene's valuation, stock price, and market status.